Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Enhanced lymphatic exposure of a chemotherapeutic drug with pegylated, nano-sized drug vectors

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: RYAN, Gemma (Monash University, Pharmaceutics, Melbourne, Australia)
  • Co-author(s): Kaminskas, Lisa (Monash University, Melbourne, Australia)
    Bulitta, J (Monash University, Melbourne, Australia)
    Michelle, Mcintosh (Monash University, Melbourne, Australia)
    Owen, David (Starpharma Pty Ltd, Melbourne, Australia)
    Porter, Chris (Monash University, Melbourne, Australia)
  • Abstract:

    I. Background: The treatment of lymph-resident cancers presents a challenge, since small molecule chemotherapeutic drugs typically have limited lymphatic access. Nano-sized drug carriers can improve lymphatic drug targeting, although to this point, it is not known which drug carriers optimally increase lymphatic exposure.
    II. Aims: To assess the..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses